Leticia Bueno

Grupo de investigación

Investigación aplicada en infecciones respiratorias y enfermo crítico Pre-doctoral researcher (R1)

bueno@recerca.clinic.cat 0000-0002-2392-8763

Publicaciones destacadas

Resistance mechanisms and molecular epidemiology of Pseudomonas aeruginosa strains from patients with Bronchiectasis

Autores:
Cabrera, Roberto; Fernandez-Barat, Laia; Vazquez, Nil; Alcaraz-Serrano, Victoria; Bueno, Leticia;

(...)

Lopez-Aladid, Ruben; Oscanoa, Patricia; Muñoz, Laura; Vila, Jordi; Torres, Antonio.

Referencia: Journal Of Antimicrobial Chemotherapy (Jac) 2022.
[Risk Factors and Clinical Impact of Fibrotic-Like Changes and the Organizing Pneumonia Pattern in Patients with COVID-19- and Non-COVID-19-induced Acute Respiratory Distress Syndrome.]

Autores:
Barbeta, Enric; Benegas, Mariana; Sanchez, Marcelo; Motos, Anna; Ferrer, Miquel;

(...)

Sandoval, Elena; Toapanta, David; Castro, Pedro; Soriano, Alex; Torres, Antoni.

Referencia: Archivos De Bronconeumologia 2022.
Label-Free Plasmonic Biosensor for Rapid, Quantitative, and Highly Sensitive COVID-19 Serology: Implementation and Clinical Validation

Autores:
Calvo-Lozano, Olalla; Sierra, Miguel; Soler, Maria; Carmen Estevez, Maria; Chiscano-Camon, Luis;

(...)

Fernandez-Barat, Laia; Attoumani, Sarah; Charrel, Remi; Coutard, Bruno; Lechuga, Laura M.

Referencia: Analytical Chemistry 2022.
Exacerbations and Changes in Physical Activity and Sedentary Behaviour in Patients with Bronchiectasis after 1 Year

Autores:
Alcaraz-Serrano, Victoria; Arbillaga-Etxarri, Ane; Oscanoa, Patricia; Fernandez-Barat, Laia; Bueno, Leticia;

Amaro, Rosanel; Gimeno-Santos, Elena; Torres, Antoni.

Referencia: Journal Of Clinical Medicine 2021.
Characteristics and Outcomes in Patients with Ventilator-Associated Pneumonia Who Do or Do Not Develop Acute Respiratory Distress Syndrome

Autores:
Barbeta, Enric; Ceccato, Adrian; Artigas, Antoni; Ferrer, Miquel; Fernandez, Laia;

(...)

Palomeque, Andrea Catalina; Panigada, Mauro; Gabarrus, Albert; de Mendoza, Diego; Torres, Antoni.

Referencia: Journal Of Clinical Medicine 2020.
SARS-CoV-2-induced Acute Respiratory Distress Syndrome: Pulmonary Mechanics and Gas Exchange Abnormalities

Autores:
Torres, Antoni; Ceccato, Adrian; Ferrer, Miquel; Cilloniz, Catia; Bueno, Leticia;

(...)

Yang, Minlan; Fernandez-Barat, Laia; Catalina Palomeque, Andrea; Vollmer, Ivan; Maria Nicolas, Jose.

Referencia: Annals Of The American Thoracic Society 2020.
Assessment of a Loop-Mediated Isothermal Amplification (LAMP) Assay for the Rapid Detection of Pathogenic Bacteria from Respiratory Samples in Patients with Hospital-Acquired Pneumonia

Autores:
Vergara, A; López, M; de la Bellacasa, JP; Marco, F; Casals-Pascual, C;

(...)

Bueno-Freire, L; Torres, A; Cruells, A; Castro, P; Moreno-Morales, J.

Referencia: Microorganisms 2020.
Lymphocytopenia as a Predictor of Mortality in Patients with ICU-Acquired Pneumonia

Autores:
Ceccato, Adrian; Panagiotarakou, Meropi; Ranzani, Otavio T; Martin-Fernandez, Marta; Almansa-Mora, Raquel;

(...)

Cilloniz, Catia; Liapikou, Adamantia; Ferrer, Miquel; Bermejo-Martin, Jesus E; Torres, Antoni.

Referencia: Journal Of Clinical Medicine 2019.
Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia

Autores:
Ceccato, Adrian; Cilloniz, Catia; Martin-Loeches, Ignacio; Ranzani, Otavio T; Gabarrus, Albert;

Buena, Leticia; Garcia-Vidal, Carolina; Ferrer, Miguel; Niederman, Michael S; Torres, Antoni.

Referencia: Chest 2019.

Proyectos destacados

ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory Disease (ECMOCARD)

Código: ECMOCARD

Duración: 16/03/2020
Fenotipos relacionados con la evolución clínica a corto y largo plazo en la NAC

Financiador: Instituto de Salud Carlos III

Código: PI19/00207

Duración: 01/01/2020
Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia (HAP2)

Investigador/a principal: Antoni Torres

Código: CE-H2020-SC1-2019-2s

Duración: 01/01/2020 - 01/01/2024
Risk factors, personalized prognosis and one-year follow-up of patients admitted to Spanish Intensive Care units infected with the COVID19 virus: CIBERESUCICOVID

Investigador/a principal: Laia Fernandez Barat

Financiador: Instituto Carlos III, ISCIII

Código: COV20/00110

Duración: 01/01/2020 - 01/01/2021
Role of Pseudomonas aeruginosa biofilms in exacerbations in patients with bronchiectasis with and without Chronic Obstructive Pulmonary Disease

Investigador/a principal: Laia Fernández Barat

Duración: 01/01/2019 - 01/01/2020

Leticia Bueno

Grupo de investigación

Publicaciones destacadas

Resistance mechanisms and molecular epidemiology of Pseudomonas aeruginosa strains from patients with Bronchiectasis

Proyectos destacados

ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory Disease (ECMOCARD)

Fenotipos relacionados con la evolución clínica a corto y largo plazo en la NAC

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia (HAP2)

Risk factors, personalized prognosis and one-year follow-up of patients admitted to Spanish Intensive Care units infected with the COVID19 virus: CIBERESUCICOVID

Role of Pseudomonas aeruginosa biofilms in exacerbations in patients with bronchiectasis with and without Chronic Obstructive Pulmonary Disease

Suscríbete a la Newsletter del Clínic